Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;52(8):1483-93.
doi: 10.1194/jlr.M014092. Epub 2011 May 23.

Hyperglycemic Ins2AkitaLdlr⁻/⁻ mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease

Affiliations

Hyperglycemic Ins2AkitaLdlr⁻/⁻ mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease

Changcheng Zhou et al. J Lipid Res. 2011 Aug.

Abstract

Accelerated atherosclerosis is the leading cause of death in type 1 diabetes, but the mechanism of type 1 diabetes-accelerated atherosclerosis is not well understood, in part due to the lack of a good animal model for the long-term studies required. In an attempt to create a model for studying diabetic macrovascular disease, we have generated type 1 diabetic Akita mice lacking the low density lipoprotein receptor (Ins2(Akita)Ldlr⁻/⁻). Ins2(Akita)Ldlr⁻/⁻ mice were severely hyperglycemic with impaired glucose tolerance. Compared with Ldlr⁻/⁻ mice, 20-week-old Ins2(Akita)Ldlr⁻/⁻ mice fed a 0.02% cholesterol AIN76a diet showed increased plasma triglyceride and cholesterol levels, and increased aortic root cross-sectional atherosclerotic lesion area [224% (P < 0.001) in males and 30% (P < 0.05) in females]. Microarray and quantitative PCR analyses of livers from Ins2(Akita)Ldlr⁻/⁻ mice revealed altered expression of lipid homeostatic genes, including sterol-regulatory element binding protein (Srebp)1, liver X receptor (Lxr)α, Abca1, Cyp7b1, Cyp27a1, and Lpl, along with increased expression of pro-inflammatory cytokine genes, including interleukin (Il)1α, Il1β, Il2, tumor necrosis factor (Tnf)α, and Mcp1. Immunofluorescence staining showed that the expression levels of Mcp1, Tnfα, and Il1β were also increased in the atherosclerotic lesions and artery walls of Ins2(Akita)Ldlr⁻/⁻ mice. Thus, the Ins2(Akita)Ldlr⁻/⁻ mouse appears to be a promising model for mechanistic studies of type 1 diabetes-accelerated atherosclerosis.

PubMed Disclaimer

Figures

Fig.1.
Fig.1.
Ins2AkitaLdlr−/− mice demonstrate insulin-deficient diabetic phenotypes. Ins2AkitaLdlr−/− mice were bred to Ldlr−/− mice to generate Ins2AkitaLdlr−/− and Ldlr−/− littermates. Four-week-old Ins2AkitaLdlr−/− and Ldlr−/− mice were fed a semisynthetic low-cholesterol AIN76a diet (0.02% cholesterol) for 16 weeks. (A) Plasma insulin and (B) glucose levels were measured by standard methods. (C, D) Intraperitoneal glucose tolerance tests (IPGTT) were performed after a 6 h fast on male (C) and female (D) Ins2AkitaLdlr−/− and Ldlr−/− mice (n = 8-14 per group, **P < 0.01 and ***P < 0.001).
Fig.2.
Fig.2.
Akita mutation induces hyperlipidemia in Ldlr−/− mice. Four-week-old male and female Ldlr−/− and Ins2AkitaLdlr−/− mice were fed a semisynthetic 0.02% cholesterol-AIN76a diet for 16 weeks. The plasma levels of (A) triglyceride and total cholesterol and (B) lipoprotein fraction cholesterols (VLDL, LDL, and HDL) were measured in male and female Ldlr−/− and Ins2AkitaLdlr−/− mice (n = 8-14 per group, *P < 0.05, **P < 0.01, and ***P < 0.001).
Fig.3.
Fig.3.
Atherosclerosis is accelerated in diabetic Ins2AkitaLdlr−/− mice. Four-week-old male and female Ldlr−/− and Ins2AkitaLdlr−/− mice were fed a semisynthetic 0.02% cholesterol AIN76a diet for 16 weeks. (A, C) Quantitative analysis of the lesion size in the aortic root of male and female Ldlr−/− and Ins2AkitaLdlr−/− mice (n = 7-13 per group, **P < 0.001 and *P < 0.05). (B, D) Representative oil red O-stained sections of atherosclerotic lesion area in the aortic root of male and female Ldlr−/− and Ins2AkitaLdlr−/− mice.
Fig.4.
Fig.4.
Hepatic genes involved in lipid homeostasis are significantly altered in Ins2AkitaLdlr−/− mice. Total RNA was isolated from the livers of 20-week-old male Ldlr−/− and Ins2AkitaLdlr−/− mice. The expression levels of hepatic genes involved in lipid homeostasis and other atherosclerosis-related genes were measured by quantitative PCR (n = 5 per group, *P < 0.05, **P < 0.01, and ***P < 0.001).
Fig.5.
Fig.5.
Akita mutation increases mRNA levels of pro-inflammatory cytokine genes in the livers of Ins2AkitaLdlr−/− mice. Total RNA was isolated from the livers of 20-week-old male Ldlr−/− and Ins2AkitaLdlr−/− mice. The expression levels of pro-inflammatory cytokine genes were measured by quantitative PCR (n = 5 per group, *P < 0.05 and ***P < 0.001).
Fig.6.
Fig.6.
Akita mutation increases the pro-inflammatory cytokine levels in the atherosclerotic lesions and artery walls of Ins2AkitaLdlr−/− mice. Sections of atherosclerotic lesion areas in the aortic root of male Ldlr−/− and Ins2AkitaLdlr−/− mice were stained with rabbit antibodies against mouse Mcp1, Tnfα, or Il1β followed by fluorescein-labeled goat anti-rabbit secondary antibody (red). The nuclei were stained with DAPI (blue).

References

    1. Calles-Escandon J., Cipolla M. 2001. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev. 22: 36–52. - PubMed
    1. Retnakaran R., Zinman B. 2008. Type 1 diabetes, hyperglycaemia, and the heart. Lancet. 371: 1790–1799. - PubMed
    1. Roglic G., Unwin N., Bennett P. H., Mathers C., Tuomilehto J., Nag S., Connolly V., King H. 2005. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 28: 2130–2135. - PubMed
    1. Coccheri S. 2007. Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs. 67: 997–1026. - PubMed
    1. Libby P., Nathan D. M., Abraham K., Brunzell J. D., Fradkin J. E., Haffner S. M., Hsueh W., Rewers M., Roberts B. T., Savage P. J., et al. 2005. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on cardiovascular complications of type 1 diabetes mellitus. Circulation. 111: 3489–3493. - PubMed

Publication types

MeSH terms